Pharma Jobs in Mumbai | Latest Pharmaceutical Openings
Explore the latest pharma jobs in Mumbai. Apply for QA, QC, Production, R&D, and regulatory affairs openings with top pharma companies.
Pharma Jobs in India Blogs
Pharma Jobs in India
Pharma Jobs in Hyderabad | Latest Pharma Openings
Explore the latest pharma jobs in Hyderabad. Apply to top pharmaceutical companies hiring for QA, QC, Production, R&D, Sales & more.
Pharma Jobs in Bangalore 2026 | Latest Pharmaceutical Jobs in Bangalore | BIG PHARMA JOBS
Explore the latest pharma jobs in Bangalore for freshers and experienced professionals. Apply for QA, QC, R&D, Production & RA jobs today.
Pharma Jobs in Pune 2026 | Latest Pharmaceutical Openings in Pune | BIG PHARMA JOBS
Explore the latest pharma jobs in Pune for freshers and experienced professionals. Apply for QA, QC, Production, RA & R&D pharma openings today.
Pharma Jobs in Ahmedabad 2026 | Latest Pharmaceutical Openings in Ahmedabad | BIG PHARMA JOBS
Explore the latest pharma jobs in Ahmedabad for freshers and experienced professionals. Apply for QA, QC, Production, RA & R&D openings today.
Recent Posts
Roche Launches AXELIOS 1: How SBX Technology Could Transform DNA Sequencing and Genomics Research
Roche has launched AXELIOS 1, a next-generation DNA sequencing platform powered by SBX technology. Discover its features, how it compares to existing sequencing systems, and what it means for genomics, clinical research, and pharma careers.
Drug Discovery Services Market to Reach US$67.3 Billion by 2035: How AI, CROs, and Biotech Are Reshaping Pharma R&D
The global drug discovery services market is expected to grow to US$67.3 billion by 2035. Discover how AI, CROs, biologics, and outsourcing are transforming pharmaceutical R&D and creating new career opportunities.
EC Approves Padcev + Keytruda for Resectable Muscle-Invasive Bladder Cancer in Europe
The European Commission has approved Padcev plus Keytruda as perioperative treatment for adults with resectable muscle-invasive bladder cancer who are ineligible for cisplatin chemotherapy.
AbbVie Gets European Commission Approval for Skyrizi in Children With Plaque Psoriasis
AbbVie has received European Commission approval for Skyrizi (risankizumab) to treat children and adolescents aged six years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy.